Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Deferred treatment for prostate cancer.

R Handley1, T W Carr, D Travis

  • 1Department of Urology, Freeman Hospital, Newcastle upon Tyne.

British Journal of Urology
|September 1, 1988
PubMed
Summary

Deferred treatment for asymptomatic prostate cancer patients resulted in a 5-year survival rate of 30%. Factors like poor tumor grade and metastatic disease indicated a worse prognosis for these men.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence-based orthopaedic trauma care in the United Kingdom: Guidelines, registries, carrots and sticks.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie·2021
Same author

Clinical management and pathogenesis of atypical fractures of the femur.

The bone & joint journal·2017
Same author

A unified theory of bone healing and nonunion: BHN theory.

The bone & joint journal·2016
Same author

Removing broken locking bolts.

Annals of the Royal College of Surgeons of England·2012
Same author

The use of an oxygen cylinder key for removal of a Hoffmann II external fixator.

Annals of the Royal College of Surgeons of England·2011
Same author

Optimising import risk mitigation: anticipating the unintended consequences and competing risks of informal trade.

Revue scientifique et technique (International Office of Epizootics)·2011

Area of Science:

  • Oncology
  • Urology
  • Clinical Medicine

Background:

  • Prostate cancer management often involves immediate treatment.
  • Deferred treatment, or watchful waiting, is an option for select asymptomatic patients.
  • Understanding outcomes for deferred treatment is crucial for clinical decision-making.

Purpose of the Study:

  • To retrospectively analyze the clinical outcomes of prostate cancer patients managed with a deferred treatment policy.
  • To identify prognostic factors associated with survival in this cohort.

Main Methods:

  • Retrospective analysis of 278 prostate cancer patients.
  • Patients were asymptomatic post-TURP or biopsy and managed expectantly.
  • Treatment (hormone therapy) was initiated only upon symptomatic progression.

Related Experiment Videos

Main Results:

  • Overall 5-year survival rate was 30%.
  • 17% died from prostate cancer, while 18% died from other causes.
  • 11% remained alive and untreated after 5 years.
  • Poor tumor grade, anemia, metastatic disease, and elevated creatinine predicted a poor prognosis.

Conclusions:

  • Deferred treatment for asymptomatic prostate cancer can lead to long-term survival in some patients.
  • However, a significant proportion may die from the disease.
  • Prognostic factors identified can help stratify risk within this management strategy.